Bio-Rad launches molecular blood screening controls in Europe

Nov. 18, 2022
News from Bio-Rad.

Bio-Rad Laboratories has announced that Exact Diagnostics HBV, HCV and HIV-1 Screen Controls are now available to laboratories in Europe. These controls are designed to monitor the performance of blood donor screening assays.    

Exact Diagnostics HBV, HCV and HIV-1 Screen Controls are calibrated against the 3rd World Health Organization International Standard for HBV (10/264), 4th WHO International Standard for HCV (06/102), and 3rd WHO International Standard for HIV-1 (10/152).    

This line of blood screening controls is intended to monitor the entire process of a variety of molecular blood donor screening assays, including extraction, amplification, and detection.  These products are made of whole viruses in a high-quality citrate plasma matrix to ensure lot-to-lot reproducibility, have an 18-month shelf life from date of manufacture (when stored at -20°C or below), and have a 24-hour stability (when stored at 2-8°C).  

Visit Bio-Rad for more news